Back to Results
First PageMeta Content
Pharmacology / Psychiatry / Piperazines / Olanzapine / Health / Antipsychotic / Treatment of bipolar disorder / Pharmaceutical drug / Hyperglycemia / Eli Lilly and Company / Atypical antipsychotics / Medicine


NEWS RELEASE Office of the Attorney General Robert E. Cooper, Jr. Department of Commerce and Insurance Commissioner Leslie Newman
Add to Reading List

Document Date: 2011-07-20 17:28:37

Open Document

File Size: 72,44 KB

Share Result on Facebook

Company

ELI LILLY / Merck / Eli Lilly and Company / Elite Pharmaceuticals Inc. / /

Currency

USD / /

Event

FDA Phase / Business Partnership / /

IndustryTerm

federal law / product samples / chemical restraint / treatment of bipolar disorder / pharmaceutical manufacturers / protection-based pharmaceutical settlement / healthcare providers / /

MedicalCondition

schizophrenia / dementia / hyperglycemia / diabetes / Parkinson’s disease / tardive dyskinesia / motion disorders / bipolar disorder / /

Organization

NEWS RELEASE office of the Attorney General Robert E. Cooper / U.S. Food and Drug Administration / Department of Commerce / Insurance / /

Person

Robert E. Cooper / Jr. / Leslie Newman / Bob Cooper / Mary Clement / Viva Zyprexa / Sharon Curtis-Flair / /

/

Position

RESOLVING IMPROPER MARKETING CLAIMS Attorney General / Affairs Director Division of Consumer / Commissioner / physician / Attorney General / Attorneys General / /

Product

olanzapine / Vioxx / Zyprexa / /

ProvinceOrState

Tennessee / /

URL

http /

SocialTag